WuXi Biologics prices HK IPO top of range as investors jostle for a piece

WuXi Biologics prices HK IPO top of range as investors jostle for a piece

06 June, 2017

Bank of America Merrill Lynch China Merchants Securities IPO Morgan Stanley WuXi Biologics WuXi Pharmatech

Printed by Unregistered user on Tue, 09 Dec 2025 12:19:00 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Venture Capital

Pop Mart backer Vision Knight Capital raises over $560m for new funds

Venture Capital

Tencent-backed SanegeneBio secures over $110m Series B